Whalegun
Lobbying

Galvanize Therapeutics's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q4 2025; the issues it reports most are Health Issues and Medicare/Medicaid.

Galvanize Therapeutics

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$30K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2025
The first quarter a report named it

Lobbying by quarter

Galvanize Therapeutics lobbying by quarter
Galvanize Therapeutics lobbying by quarter
QuarterAmountReports
Q4 2025$15K1
Q1 2026$15K1
Q2 2026$01
Q3 2026$00

By issue

  • Health issues$15K · 2 reports
  • Medicare and Medicaid$15K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
Jeffrey J. Kimbell & Associates$30K3 quarters

Former officials lobbying for it

Former position
BRETT MEEKSDeputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar AlexanderQ1 2026
JOHN HERZOGHealth Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the PresidentQ1 2026
JOHN R RAYLegislative Assistant, Rep. Mike KellyQ1 2026
KEITH STUDDARDLegislative Director, Rep. Marsha BlackburnQ1 2026
LAURA KEMPERCounsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human ServicesQ1 2026

Lobbying reports

Filed by
05/29for Q2Jeffrey J. Kimbell & AssociatesUnder $5,000
04/20for Q1Jeffrey J. Kimbell & Associates$15K
01/20for Q4 2025Jeffrey J. Kimbell & Associates$15K
25/12/05for Q4 2025Jeffrey J. Kimbell & AssociatesUnder $5,000